GLP-1 Weight Loss in Manchester (2026)

168 GLP-1 telehealth providers ship to Manchester, New Hampshire. Compounded semaglutide averages $219/month — same active ingredient as Wegovy and Ozempic, a fraction of the cost.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Featured Partners · Manchester

Featured GLP-1 providers serving Manchester

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $179/mo

    Save $1,170/mo vs Wegovy
    Get started →
  5. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  6. Compounded from

    $146/mo

    Save $1,203/mo vs Wegovy
    Get started →

Manchester at a Glance

Manchester population
115,644
City proper
Metro-area population
422,937
Wider telehealth market
New Hampshire obesity rank
#34 of 50
1 = highest prevalence
New Hampshire avg. compounded price
$219/mo
Semaglutide, cash-pay

About GLP-1 Access in Manchester

Manchester is a major city in New Hampshire with a population of approximately 115,644 residents. Telehealth is legal in New Hampshire, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Manchester ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

The greater Manchester metro area is home to roughly 422,937 residents — one of the larger telehealth markets in New Hampshire, even though the city proper is smaller.

New Hampshire's adult obesity rate is approximately 32.8% based on CDC Behavioral Risk Factor Surveillance System data[2], and state rankings are published in CDC's Adult Obesity Facts[3]. New Hampshire ranks #34 of 50 states for adult obesity prevalence — near the national middle — and telehealth gives Manchester residents a fast, private alternative to scheduling with a local obesity-medicine specialist. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.

New Hampshire Medicaid does not currently cover GLP-1s for weight loss alone (Limited), which is why cash-pay compounded semaglutide or tirzepatide — averaging $219/month — is the realistic path for most Manchester residents seeking obesity treatment outside a type 2 diabetes diagnosis.

Looking beyond Manchester? See all GLP-1 providers in New Hampshire, or read our New Hampshire Medicaid GLP-1 coverage & prior-authorization guide.

Browse by Medication

All GLP-1 Providers Serving Manchester

1

Found

Verified partner

Best for: mainstream telehealth GLP-1 access

8.3

Personalized weight care platform with a self-pay membership model plus medication costs.

Score Breakdown

Value25%
8.5
Effectiveness25%
9
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
8.5
Support10%
7.5

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Cons

  • Limited public information on program details
2

CoreAge Rx

Verified partner

Best for: best overall value

8.3

CoreAge Rx offers LegitScript-verified compounded semaglutide and tirzepatide with free 2-day shipping to all 50 states. Backed by licensed physicians and 24/7 support, it delivers the most competitive pricing in the compounded GLP-1 space.

Score Breakdown

Value25%
8.5
Effectiveness25%
8.5
User Experience15%
8.5
Trust & Safety15%
7.8
Accessibility10%
8
Support10%
8.4

Pros

  • LegitScript certified — rigorous pharmacy standards
  • Free 2-day shipping nationwide
  • Both semaglutide and tirzepatide available
  • Lowest per-month pricing in the compounded segment
  • 24/7 support team
  • All 50 states covered

Cons

  • Compounded only — no brand-name Ozempic or Wegovy
  • Newer brand with fewer independent reviews than legacy players
3

Enhance MD

Verified partner

Best for: lab-monitored compounded GLP-1 with mandatory video visit

8.2

Enhance MD pairs compounded semaglutide and tirzepatide with mandatory baseline metabolic labs at Quest Diagnostics and a synchronous video visit with a board-certified clinician — a more rigorous onboarding than the async-only compounded GLP-1 model most telehealth providers use. Three tiers (Core semaglutide, Advanced tirzepatide, Elite combined) plus $100-off-first-order intro pricing ($112 first month on Core with code SUMMER100).

Score Breakdown

Value25%
7
Effectiveness25%
9
User Experience15%
8.5
Trust & Safety15%
8
Accessibility10%
8.5
Support10%
8.9

Pros

  • Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
  • Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
  • Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
  • Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
  • Intro pricing via $100 off your first order (code SUMMER100): $112 Core, $180 Advanced, $222 Elite first month
  • Unlimited clinician messaging and dose-adjustment support included

Cons

  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
  • Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
  • No insurance accepted — cash pay, HSA/FSA eligible
  • Intro discount applies only to the first order — ongoing rates are $212–$322/mo on 12-month plans, or $249–$379/mo month-to-month
4

Gala

Verified partner

Best for: compounded GLP-1/GIP combo on a yearly plan with free shipping

8.2

Gala (legal entity AI Coaching Inc., d/b/a Gala GLP-1) is a Delaware-incorporated telehealth platform selling compounded GLP-1/GIP (tirzepatide) on a yearly subscription, a lower-priced microdosing version of the same protocol, and brand-name Ozempic. It does not sell a compounded semaglutide product. The marketing site claims licensed providers in all 50 states with free shipping included. An oral Wegovy pill option is listed as 'coming soon.'

Score Breakdown

Value25%
8.5
Effectiveness25%
8.5
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
8
Support10%
8.4

Pros

  • Compounded semaglutide and tirzepatide at $179/mo with all doses included on the yearly plan
  • Lower microdosing tirzepatide tier at $149/mo for a sub-therapeutic starting protocol
  • Brand-name Ozempic available alongside compounded options
  • Claims licensed providers in all 50 states with free shipping included
  • 24/7 support, provider visit included, cancel anytime
  • LegitScript verified

Cons

  • $179/mo requires a yearly subscription — the standalone monthly price isn't published
  • Brand-name Ozempic at $1,299/mo is higher than peers (e.g., Found at $1,100/mo)
  • Pharmacy partners not named — only a "network of pharmacies" reference
  • Wegovy oral pill listed as "coming soon," not yet available
  • Per-state availability isn't listed; the all-50-states claim is gated behind intake
5

Pallas Health

Verified partner

Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found

8.1

Pallas Health is a telehealth platform operated by Brentmoor, Inc. offering compounded semaglutide and tirzepatide alongside brand-name Wegovy, Ozempic, Zepbound and Mounjaro. Compounded plans average $199 and $299 a month with provider care, check-ins and messaging included and no separate membership fee, and the price stays the same at every dose. Its clinical disclosures page is unusually complete: two named advising physicians with verifiable NPIs, the clinical partner Lion MD, six named partner pharmacies, and coverage in all 50 states plus DC.

Score Breakdown

Value25%
7.5
Effectiveness25%
8
User Experience15%
8.5
Trust & Safety15%
8
Accessibility10%
9
Support10%
8

Pros

  • Names six partner pharmacies with phone numbers and websites, the most complete pharmacy disclosure we have recorded.
  • Publishes two advising physicians with NPI numbers you can verify yourself in the federal NPPES registry.
  • Price stays the same at every dose, and provider care, check-ins and messaging are included with no membership fee.
  • Offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro alongside compounded options, and serves all 50 states plus DC.

Cons

  • Billed $597 every 12 weeks, not monthly; at 4.33 cycles a year the true cost is about $216/mo, above the $199 advertised.
  • The homepage claims "200,000+ patients" while the clinical page describes a July 2026 launch and existing waitlist patients.
  • Canceling after a payment deducts third-party processing costs plus a $5 fee per refunded payment.
  • In states requiring a live video visit a $60 deposit is taken at checkout, and it may be retained if you abandon the intake.
Browse all 168 GLP-1 providers serving Manchester A–Z

Also consider: 305 providers with undisclosed state coverage

These providers offer GLP-1 weight loss service (verified on their own websites) but do not publish a complete state-availability list publicly — their intake flow determines eligibility. We have not independently confirmed Manchester coverage for the providers below. Start the signup intake to check whether they serve your area before proceeding.

6.4/ 10
Verified partner

Direct Meds

Best for: listed for disclosure only — see its FDA warning and BBB complaints first

★★★☆☆3.2/5

Editorial score · methodology

$249/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript VerifiedFDA Warning
Get StartedRead full Direct Meds review →
8.0/ 10
Verified partner

Sesame Care

Best for: Brand-name GLP-1s at cash prices, no compounding

★★★★4/5

Editorial score · methodology

$149/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideOrforglipron
Get StartedRead full Sesame Care review →
6.9/ 10
Verified partner

Try Ageless

Best for: lowest-tier compounded GLP-1 in injection, troche and sublingual forms

★★★3.5/5

Editorial score · methodology

$119/mosemaglutide
$169/motirzepatide
CompoundedSemaglutideTirzepatideGonadorelinNAD+LegitScript Verified
Get StartedRead full Try Ageless review →
7.3/ 10
Verified partner

Sunlight

Best for: compounded GLP-1 with unlimited telehealth visits and free shipping

★★★3.7/5

Editorial score · methodology

$88/mosemaglutide
$157/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full Sunlight review →
7.4/ 10
Verified partner

MadeMed

Best for: compounded GLP-1 in both injection and oral forms

★★★3.7/5

Editorial score · methodology

$219/mosemaglutide
$299/motirzepatide
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full MadeMed review →
7.4/ 10
Verified partner

Telos Rx

Best for: Needle-free, microdosed compounded GLP-1 with lab-monitored care

★★★3.7/5

Editorial score · methodology

$99/mosemaglutide
$116/motirzepatide
CompoundedSemaglutideTirzepatideBPC-157CJC-1295 / Ipamorelin
Get StartedRead full Telos Rx review →

Browse all 305 providers with undisclosed coverage on the New Hampshire page →

In-Person vs Telehealth in Manchester

Patients in Manchester have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to New Hampshire addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in New Hampshire varies by plan[4].

In-person weight-management clinics in Manchester (21 in our directory)

From the NPI registry, cross-checked against obesity-medicine and bariatric taxonomy codes — mostly endocrinology, diabetes & metabolism.

Browse all 21 Manchester clinics in the directory →

Cost of GLP-1 Medications in Manchester

Average compounded semaglutide (New Hampshire)[1]
$219/month

Brand-name Wegovy in Manchester typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $219/month in New Hampshire, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.

Frequently Asked Questions

Manchester residents can get GLP-1 medications through licensed telehealth providers that ship compounded semaglutide or tirzepatide directly to New Hampshire addresses, or by seeing a local clinician in person and filling a brand-name prescription (Wegovy, Zepbound, Ozempic, Mounjaro) at a retail pharmacy. Telehealth providers that serve New Hampshire are listed above, and our directory tracks 21 in-person weight-management clinics in Manchester itself.
Yes. Our clinic directory lists 21 weight-management practices in Manchester, NH, drawn from the NPI registry and matched on obesity-medicine, bariatric, and related taxonomy codes — most commonly endocrinology, diabetes & metabolism. In-person care is usually the better path when insurance covers a brand-name GLP-1 and requires documented visits; the ranked telehealth list above is usually the cheaper cash-pay path.
Yes — telehealth prescribing of GLP-1 medications is legal in New Hampshire. Licensed providers can conduct an online evaluation, prescribe semaglutide or tirzepatide when clinically appropriate, and arrange delivery to your address through a partner pharmacy.
Compounded semaglutide pricing is set at the provider level, not the city level, and varies by dose and plan. See the pricing columns on each provider card above for the current monthly cost from providers that serve New Hampshire. Brand-name Wegovy and Zepbound retail list prices are $1,000-$1,350 per month without insurance.
Insurance coverage in Manchester follows New Hampshire plan-level rules. Most commercial plans cover Ozempic and Mounjaro for type 2 diabetes diagnoses, but coverage for Wegovy and Zepbound (the obesity-indicated versions) is much more limited and typically requires prior authorization. Check your plan's formulary for the specific drug and indication you need.
The lowest-cost route for Manchester residents is usually compounded semaglutide or tirzepatide through telehealth, averaging around $219/month in New Hampshire — well below brand-name Wegovy ($1,349/mo) or Zepbound ($1,086/mo) without insurance. Compare current pricing from providers serving Manchester above, or check if your insurance covers a brand-name option first.
New Hampshire Medicaid coverage for GLP-1 weight-loss medication is currently: Limited. Ozempic and Mounjaro are generally covered for type 2 diabetes, while the obesity-indicated versions (Wegovy, Zepbound) typically require prior authorization or aren't covered at all, depending on the plan.
168 GLP-1 telehealth and in-person providers currently serve Manchester residents, based on our tracked pricing and availability data. See the full ranked list above, or browse the A-Z index for every provider that ships to New Hampshire.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Get Manchester Price Alerts

Be the first to know about new GLP-1 providers and price changes in Manchester.

Sources & methodology — as of August 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)WeightLossRankings.org.
  2. 2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)Centers for Disease Control and Prevention.
  3. 3.CDC — State Obesity Rankings and Adult Obesity FactsCenters for Disease Control and Prevention.
  4. 4.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  5. 5.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.